If you’ve flown in the U.S. in recent years, you’re probably familiar with the airport security experience of entering a booth, raising your hands above your head, and having a machine check your body. That machine is called a millimeter wave scanner.

Increasingly, inspectors for the U.S. Food and Drug Administration (FDA) will evaluate your CMMS provider’s security controls—not just your internal procedures.

Early-stage medtech companies are under tremendous pressure to develop quickly, prove value, and obtain regulatory approval or clearance as fast as possible.

In today’s digital age, the question isn’t whether you’ll experience a cybersecurity attack, but when this might occur. Cybercriminals strike when you least expect it, with devastating consequences for your day-to-day operations.

In manufacturing, failure isn’t an option—it’s a liability. A defective part or a missed delivery triggers a chain reaction that can disrupt schedules, undermine trust, and drain resources.

In 2025, there’s been a marked increase in FDA warning letters. During the second quarter of 2025 alone, the U.S. Food and Drug Administration (FDA) issued 172 warning letters.

Even the smallest manufacturer would never consider using a typewriter to develop an invoice, or manage a sales prospect list from a Rolodex.

Quality has always been a defining metric in manufacturing when it comes to industry trust, brand longevity, and customer loyalty. Manufacturers are already expected to abide by stringent regulations.

From manufacturing and mining to hospitality and healthcare, computerized maintenance management systems (CMMS) have become all but essential.

Physical AI—the embedding of digital intelligence into physical systems—is a promising but sometimes polarizing technology.